Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 9 Neoplasms 7 Neoplasm Metastasis 5 Carcinoma, Non-Small-Cell Lung 5 Recurrence 4 Prostatic Neoplasms 4 Melanoma 4 Breast Neoplasms 4 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma 3 Head and Neck Neoplasms 3 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycystic Ovary Syndrome 2 Pleural Effusion, Malignant 2 Mesothelioma, Malignant 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Anxiety Disorders 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Rare Malignant Neoplasm 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Nephrotic Syndrome 1 Neoplasms, Plasma Cell 1 NSCLC 1 Myeloproliferative Disorders 1 Multiple Myeloma 1

Interventions

Temozolomide 163 Radiosurgery 129 Radiotherapy 107 Bevacizumab 98 Magnetic Resonance Spectroscopy 75 Carboplatin 48 Surgical Procedures, Operative 35 pembrolizumab 34 Radiation 34 Etoposide 34 Nivolumab 33 Irinotecan 33 Cyclophosphamide 33 Erlotinib Hydrochloride 31 Carmustine 28 Lomustine 26 Trastuzumab 25 Cisplatin 25 Ipilimumab 24 Filgrastim 23 Mental Status and Dementia Tests 21 Magnetic Resonance Imaging 21 Aminolevulinic Acid 21 Vincristine 20 Surveys and Questionnaires 19 Capecitabine 19 Topotecan 18 Specimen Handling 18 Pemetrexed 18 Radiotherapy, Intensity-Modulated 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × Pharmaceutical Preparations × Clear all

NCT03338075 2017-11-09

FSRT Combined With TMZ for Large BMs: a PSM Study

ChineseAMS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡